Lonza Group AG (LZAGY)
USD 68.65
(1.48%)
USD 68.65
(1.48%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 654 Million CHF | -46.17% |
| 2022 | 1.21 Billion CHF | -58.73% |
| 2021 | 2.94 Billion CHF | 238.78% |
| 2020 | 869 Million CHF | 34.73% |
| 2019 | 645 Million CHF | 15.38% |
| 2018 | 559 Million CHF | -20.93% |
| 2017 | 707 Million CHF | 134.88% |
| 2016 | 301 Million CHF | 8.66% |
| 2015 | 277 Million CHF | 16.88% |
| 2014 | 237 Million CHF | 172.41% |
| 2013 | 87 Million CHF | -50.0% |
| 2012 | 174 Million CHF | 12.99% |
| 2011 | 154 Million CHF | -47.08% |
| 2010 | 291 Million CHF | 79.63% |
| 2009 | 162 Million CHF | -61.43% |
| 2008 | 420 Million CHF | 39.53% |
| 2007 | 301 Million CHF | 35.59% |
| 2006 | 222 Million CHF | 18.09% |
| 2005 | 188 Million CHF | 36.23% |
| 2004 | 138 Million CHF | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 329 Million CHF | 34.84% |
| 2023 Q2 | 410 Million CHF | -43.29% |
| 2023 FY | 654 Million CHF | -46.17% |
| 2023 Q4 | 244 Million CHF | -40.49% |
| 2022 Q2 | 492 Million CHF | -81.26% |
| 2022 Q4 | 723 Million CHF | 46.95% |
| 2022 FY | 1.21 Billion CHF | -58.73% |
| 2021 Q4 | 2.62 Billion CHF | 722.88% |
| 2021 Q2 | 319 Million CHF | -18.62% |
| 2021 FY | 2.94 Billion CHF | 238.78% |
| 2020 Q2 | 477 Million CHF | 28.92% |
| 2020 FY | 869 Million CHF | 34.73% |
| 2020 Q4 | 392 Million CHF | -17.82% |
| 2019 Q2 | 392 Million CHF | 47.37% |
| 2019 FY | 645 Million CHF | 15.38% |
| 2019 Q4 | 370 Million CHF | -5.61% |
| 2018 Q4 | 266 Million CHF | -31.62% |
| 2018 FY | 559 Million CHF | -20.93% |
| 2018 Q2 | 389 Million CHF | 0.0% |
| 2017 Q4 | - CHF | -100.0% |
| 2017 Q2 | 227 Million CHF | 112.15% |
| 2017 FY | 707 Million CHF | 134.88% |
| 2016 Q4 | 107 Million CHF | -44.85% |
| 2016 Q2 | 194 Million CHF | 16.87% |
| 2016 FY | 301 Million CHF | 8.66% |
| 2015 Q2 | 111 Million CHF | 14.43% |
| 2015 Q4 | 166 Million CHF | 49.55% |
| 2015 FY | 277 Million CHF | 16.88% |
| 2014 Q4 | 97 Million CHF | -30.71% |
| 2014 FY | 237 Million CHF | 172.41% |
| 2014 Q2 | 140 Million CHF | 204.35% |
| 2013 Q4 | 46 Million CHF | 12.2% |
| 2013 Q2 | 41 Million CHF | 0.0% |
| 2013 FY | 87 Million CHF | -50.0% |
| 2012 FY | 174 Million CHF | 12.99% |
| 2012 Q4 | - CHF | 0.0% |
| 2011 Q4 | - CHF | 0.0% |
| 2011 FY | 154 Million CHF | -47.08% |
| 2010 FY | 291 Million CHF | 79.63% |
| 2010 Q4 | - CHF | 0.0% |
| 2009 Q4 | - CHF | 0.0% |
| 2009 FY | 162 Million CHF | -61.43% |
| 2008 FY | 420 Million CHF | 39.53% |
| 2008 Q4 | - CHF | 0.0% |
| 2007 FY | 301 Million CHF | 35.59% |
| 2006 FY | 222 Million CHF | 18.09% |
| 2005 FY | 188 Million CHF | 36.23% |
| 2004 FY | 138 Million CHF | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | 46482.979% |
| Arrayit Corporation | -3.31 Million USD | 19824.972% |
| Atlantic International Corp. | -5.62 Million USD | 11721.314% |
| Biocept, Inc. | -32.08 Million USD | 2138.209% |
| Bioqual, Inc. | 483.48 Thousand USD | -135169.018% |
| CardioGenics Holdings Inc | -1.91 Million USD | 34227.841% |
| DermTech, Inc. | -100.88 Million USD | 748.244% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 67.701% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 3128.552% |
| iMD Companies, Inc. | -200.63 Thousand USD | 326063.436% |
| IDenta Corp. | 14.64 Thousand USD | -4465892.898% |
| Interpace Biosciences, Inc. | 802 Thousand USD | -81446.135% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | -1690302.957% |
| InVitro International | 1553.00 USD | -42111941.211% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 7711.732% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 1125512.996% |
| Medical Imaging Corp. | -3.02 Million USD | 21733.967% |
| NovelStem International Corp. | -4.18 Million USD | 15718.656% |
| Optigenex Inc. | -2.89 Million USD | 22669.157% |
| PharmChem, Inc. | 845.1 Thousand USD | -77287.108% |
| Proteome Sciences plc | -2.44 Million USD | 26870.364% |
| Response Genetics, Inc | -20.18 Million USD | 3340.19% |
| Rennova Health, Inc. | -3.29 Million USD | 19959.978% |
| RushNet, Inc. | -607.02 Thousand USD | 107838.029% |
| ScreenPro Security Inc. | -2.24 Million USD | 29182.604% |
| Stella Diagnostics Inc. | -5.7 Million USD | 11558.752% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 5829.117% |
| Todos Medical Ltd. | -24.99 Million USD | 2716.628% |